Live Feed

Delayed 3m

Press · Insider · SEC · FDA

Signed out · 3-min delay · Sign up for real-time

PR22:00:00·1h·Consumer Staples·
$RKDA
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative wellness products, announced today the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the purchase and sale of 3,883,496 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock and Series A-2 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock at a purchase price of $1.03 per share of common stock (or pre-funded warrant in lieu thereof) and associated preferr
INSIDER21:58:25·1h·Technology·
$PCOR
Chairman of the Board Courtemanche Craig F. Jr. exercised 56,122 shares at a strike of $2.42 and sold $2,533,545 worth of shares (56,122 units at $45.14) as part of a pre-agreed trading plan (SEC Form 4)
4 - PROCORE TECHNOLOGIES, INC. (0001611052) (Issuer)
INSIDER21:55:05·1h·Technology·
$IONQ
CFO & COO Singh Inder M covered exercise/tax liability with 6,272 shares, decreasing direct ownership by 1% to 417,503 units (SEC Form 4)
4 - IonQ, Inc. (0001824920) (Issuer)
INSIDER21:55:03·1h·Technology·
$IONQ
Executive Chair, IonQ Federal Cardillo Robert T. covered exercise/tax liability with 904 shares, decreasing direct ownership by 0.65% to 139,063 units (SEC Form 4)
4 - IonQ, Inc. (0001824920) (Issuer)
INSIDER21:55:05·1h·Technology·
$IONQ
President and CEO De Masi Niccolo covered exercise/tax liability with 16,120 shares, decreasing direct ownership by 1% to 1,139,547 units (SEC Form 4)
4 - IonQ, Inc. (0001824920) (Issuer)
INSIDER21:55:07·1h·Industrials·
$GRMN
Executive Chairman Kao Min H gifted 11,005 units of Registered Shares (SEC Form 4)
4 - GARMIN LTD (0001121788) (Issuer)
INSIDER21:55:03·1h·Technology·
$IONQ
CAO, CLO and Secretary Dacier Paul T covered exercise/tax liability with 4,110 shares, decreasing direct ownership by 4% to 104,458 units (SEC Form 4)
4 - IonQ, Inc. (0001824920) (Issuer)
INSIDER21:50:45·1h·Consumer Discretionary·
$GOLF
Principal Accounting Officer Mohamed Nicholas N sold $50,241 worth of shares (529 units at $95.00), decreasing direct ownership by 16% to 2,868 units (SEC Form 4)
4 - Acushnet Holdings Corp. (0001672013) (Issuer)
INSIDER21:44:15·1h·Health Care·
$PRKS
Chief Commercial Officer Finazzo Christopher L. sold $294,080 worth of shares (8,000 units at $36.76), decreasing direct ownership by 6% to 130,285 units (SEC Form 4)
4 - United Parks & Resorts Inc. (0001564902) (Issuer)
INSIDER21:43:47·1h·Health Care·
$PRKS
Officer Miller Kyle Robert was granted 12,459 shares, increasing direct ownership by 32% to 51,954 units (SEC Form 4)
4 - United Parks & Resorts Inc. (0001564902) (Issuer)
INSIDER21:43:06·1h·Health Care·
$PRKS
Officer Forrester James W Jr was granted 1,245 shares, increasing direct ownership by 5% to 27,883 units (SEC Form 4)
4 - United Parks & Resorts Inc. (0001564902) (Issuer)
INSIDER21:30:56·1h·Technology·
$KULR
General Counsel & Secretary Yamamoto Jay Koichi covered exercise/tax liability with 9,507 shares, decreasing direct ownership by 5% to 168,500 units (SEC Form 4) (withholding obligation)
4 - KULR Technology Group, Inc. (0001662684) (Issuer)
INSIDER21:30:10·1h·Technology·
$KULR
New insider Perez Steven John claimed ownership of 1,250 shares (SEC Form 3)
3 - KULR Technology Group, Inc. (0001662684) (Issuer)
PR21:30:00·1h·Health Care·
$BLTE
Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1
SAN DIEGO, June 12, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ:BLTE) ("Belite Bio®" or the "Company"), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced the completion of its rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tinlarebant. Tinlarebant is an investigational, once-daily oral therapy for the treatment of Stargardt disease type 1 (STGD1), a rare, inherited retinal disease caused by mutations in the ABCA4 gene that leads to progressive and irreversible vision loss. STGD1 affects an estimated 53
PR21:25:00·1h·Utilities·
$EXC
ComEd Continues Power Restoration Following Two Powerful Storms
Crews focus on remaining outages as weather clears across northern Illinois ComEd crews continue restoring power to customers impacted by multiple rounds of severe storms that moved through northern Illinois beginning Wednesday afternoon. With the most volatile weather now past the region, crews are focused on completing repairs and restoring service to remaining pockets of customers affected by storm damage. Multiple bands of severe weather brought intense rain, frequent lightning and high wind gusts, causing significant damage to ComEd's power infrastructure and resulting in widespread outages across the service territory. At least two tornadoes were confirmed on Thursday, including o
INSIDER21:21:06·1h·Telecommunications·
$ROKU
Director Luna Gina converted options into 1,847 shares, increasing direct ownership by 30% to 7,955 units (SEC Form 4)
4 - ROKU, INC (0001428439) (Issuer)
INSIDER21:17:43·1h·Consumer Discretionary·
$TK
President and CEO Hvid Kenneth sold $82,146 worth of shares (6,822 units at $12.04), decreasing direct ownership by 6% to 105,500 units (SEC Form 4)
4 - TEEKAY CORP LTD (0000911971) (Issuer)
INSIDER21:17:13·1h·Telecommunications·
$ROKU
Director Blackburn Jeffrey M converted options into 1,847 shares, increasing direct ownership by 15% to 14,040 units (SEC Form 4)
4 - ROKU, INC (0001428439) (Issuer)
INSIDER21:14:42·1h·Telecommunications·
$ROKU
Director Fyfield Mai converted options into 1,847 shares and sold $99,540 worth of shares (832 units at $119.64), increasing direct ownership by 23% to 5,389 units (SEC Form 4) (withholding tax)
4 - ROKU, INC (0001428439) (Issuer)
INSIDER21:13:32·1h·Telecommunications·
$ROKU
Director Hodrick Laurie Simon converted options into 1,847 shares, increasing direct ownership by 30% to 7,955 units (SEC Form 4)
4 - ROKU, INC (0001428439) (Issuer)